Skip to content

Jeevaniya dravya sidhha ghrita nasya and netratarpan in comparison with lubricant eyedrops in dry eye disease

A Randomized Controlled Clinical Trial of Jeevaniya Dravya siddha Ghrita Nasya and Netratarpan in comparison with Carboxymethyl Cellulose (0.5%) eyedrops in Shushkakshipaka with special reference to Dry Eye Disease. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/089929
Enrollment
60
Registered
2025-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H578- Other specified disorders of eye and adnexa

Interventions

None listed

Sponsors

Ayurved Vidya Prasarak Mandals Ayurved Mahavidyalaya Sion
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients showing symptoms of Shushkakshipaka (Dry Eye Syndrome) 2. Patients with dryness of eyes with or without pain/pricking sensation, photophobia, and mild redness, less flow of tears, foreign body sensation, scratchy sandy feeling and itching. 3. Patients with score less than 15mm on Schirmer s test

Exclusion criteria

Exclusion criteria: 1. Age below 30 years and above 70years 2. Patients having corneal ulcers. 3. Patients having congenital absence of meibomian glands. 4. Patients having other eye diseases. 5. Patients having systemic diseases like uncontrolled diabetes mellitus, hypertension. 6. Patients having ocular infections

Design outcomes

Primary

MeasureTime frame
Jeevaniya dravya siddha ghrita Nasya with Netratarpan is significantly effective than carboxy methyl cellulose (o.5%) eye drops in the management of Shushkakshipaka 9Dry Eye Syndrome).Timepoint: follow up on 0th, 7th, 14th, 21st, 42nd day

Secondary

MeasureTime frame
Jeevaniya dravya siddha ghrita Nasya with Netratarpan is not effective than carboxy methyl cellulose (o.5%) eye drops in the management of Shushkakshipaka 9Dry Eye Syndrome).Timepoint: follow up on 0th, 7th, 14th, 21st, 42nd day

Countries

India

Contacts

Public ContactDr Adarsh Ramkalap Sharma

Ayurved Mahavidyalaya Sion, Maharashtra University of Health Sciences

ravimore67@gmail.com9967483930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026